about
Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectivesMeasurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm.IgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis.Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes.Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies.Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management."Metabolic and cardiovascular response to exercise in patients with type 1 diabetes".The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study.The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol.Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.Altered IgG(4) renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity.Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7.Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: a cohort study.The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals.Two polyclonal antisera detect different AGE epitopes in human plasma samples.High circulating vascular endothelial growth factor (VEGF) is related to a better systolic function in diabetic hypertensive patients.Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects.Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.Screening for Type 1 Diabetes-, Thyroid-, Gastric-, and Adrenal-Specific Humoral Autoimmunity in 529 Children and Adolescents With Celiac Disease at Diagnosis Identifies as Positive One in Every Nine Patients.Impact of risk factors for gestational diabetes (GDM) on pregnancy outcomes in women with GDM.Linking type 2 diabetes and gynecological cancer: an introductory overview.Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.Assessment of fracture risk by the FRAX algorithm in men and women with and without type 2 diabetes mellitus: a cross-sectional study.Transaminase levels in the upper normal range are associated with oral hypoglycemic drug therapy failure in patients with type 2 diabetes.Assessment of trabecular bone score (TBS) in overweight/obese men: effect of metabolic and anthropometric factors.Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin.High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.Gender-dependent association of type 2 diabetes with the vasoactive intestinal peptide receptor 1.The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes.Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction.Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction.Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes.Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study.Role of advanced glycation end-products (AGE) in late diabetic complications.Characteristics of proteinuria in experimental diabetes mellitus.
P50
Q26765972-CA8E0713-258D-40A4-9684-A3D4A281B0C7Q34741840-0E83D498-4854-4F71-A0D6-2119C4E4E9C9Q36249568-8DF84FAF-81CA-4AD7-8098-1EDC95AEC5D9Q36334589-3CA24C4E-D3BF-44BC-8334-822B3E7E40F4Q37113138-0E033192-2F3C-47E8-9DC2-DCD10365C8D1Q37269502-C7D51E7E-AB9A-43A0-80B8-2B6DC2051C4BQ38684361-D3418E84-9C35-4000-A8AA-E159A86AD004Q38728370-BE22C526-7E26-4085-9109-99CF0F50E015Q39109851-9D15A182-2D8B-49AC-9AAB-FD5962F10F95Q40260967-E4F8DEE8-9E90-4A2F-9A2A-BC6E18060421Q41014625-BCA7B33E-FDE3-42A2-90EC-FC53F2EBF00FQ41026601-804E8CF8-4170-43D9-9BC8-5F9F82C78715Q41138317-6151F291-7764-4DF6-A05E-3734D11C71C4Q41726079-841B4F96-3719-4097-8DF9-6B89AEC94EE3Q42125804-C874AE63-1557-4622-8983-58A8554F1910Q43281494-8F5C1ECB-B35C-4535-8693-A1D26FF88564Q43496325-3CE6C4D7-6F6F-456A-AD91-10D67B8516DAQ44380962-E7CA1DD3-55E7-4DBD-A356-6722068325BDQ44944483-1BDED73F-2D5E-4BA7-95EB-3C6D79B5915AQ45983627-2D540890-95FA-4960-A92E-BAC72A0E410DQ46779332-14CA83E4-A905-4DF7-B7FB-F3C123149A57Q46940645-AB5A597E-5BC7-49E9-9E38-64A020B79621Q46945308-6ACB4BF4-A67D-4CE0-ABCF-BA5863E29C1CQ48189975-5825A4A1-4DD2-4E36-B9CA-91DB92C61D1FQ49909106-634EEAA6-5DF0-4EAC-9E19-CAFB4274A8D7Q50087415-4C0BE381-2E01-42E7-9CF9-91C7E269F2E1Q50798695-F2AAF37A-AF61-4069-BD3D-D20712ABF2E8Q51123817-214AE454-CBF4-4370-8A97-D403D14BAF01Q51158595-538F82D6-3709-40CE-B51F-1B0285D911C6Q51277297-47E241B7-E72B-4909-A151-D2E3A3D3CF81Q51277732-672EC30C-849B-4A7E-850A-80B067C44084Q51307372-1F4D3362-6073-4D80-9CD1-404878EA4A94Q51375974-D4EED591-D502-40FD-95D2-F0E461E200B4Q51459051-B3D8BAAC-E5B0-48E3-A616-0CC734D33EC5Q51599067-2125B10B-6846-41AC-B4C7-41C7736DE1A9Q53243466-AC34BF0C-1FE6-4184-96FD-2EF0E5ED1C57Q53424876-B7E9044A-31A5-4168-BCF5-DCA95B70D30BQ53640778-6983BFD9-0D67-4027-96E3-36113AED8262Q53709041-997296AB-7D8E-4F3C-B683-61E6C913F107Q54505624-B42B14E2-97EA-41E2-A95A-6D184CD91A42
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Susanna Morano
@ast
Susanna Morano
@en
Susanna Morano
@es
Susanna Morano
@nl
Susanna Morano
@sl
type
label
Susanna Morano
@ast
Susanna Morano
@en
Susanna Morano
@es
Susanna Morano
@nl
Susanna Morano
@sl
prefLabel
Susanna Morano
@ast
Susanna Morano
@en
Susanna Morano
@es
Susanna Morano
@nl
Susanna Morano
@sl
P1053
A-6995-2014
P106
P1153
7004213756
P21
P2798
P31
P3829
P496
0000-0002-8156-9543